NanoViricides Inc. (NNVC)

[BonelessCat]

Since there is no wholistic assessment for Ebola, and only hard data--hours of survival after administration, viral load reduction, etc-- there is no point to a blinded study. Even in humans, since there is no standard of care other than hydration, fever control, etc, the control is already present in every other patient, so there is no blinded study, unless one wishes to do a 3 arm control study with those using standard of care, those treated and those with no care whatsoever, which is unethical. There is no need to blind as the clinical outcomes would include effect on cytokine and other metrics beyond comparative rates of survival, those drug treated and the rest of the afflicted. Again, blinding is unethical.